company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2297000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2297000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2297000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1552000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5041000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6593000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4296000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4288000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4288000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4288000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4288000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39000000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39000000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38347000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:10:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2301000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2301000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2301000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1578000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4965000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6543000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4242000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,15000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4227000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4227000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4227000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4227000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38400000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38400000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38383000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:15:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,435000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,435000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,435000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1884000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4412000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6296000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5861000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,28000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5833000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5833000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5833000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5833000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50367000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,460000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,460000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,460000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2729000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4315000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7044000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6584000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,28000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6556000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6556000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6556000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6556000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52677000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:10:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,584000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,584000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,584000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1519000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4158000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5677000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5093000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,17000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,17000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5076000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5076000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5076000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5076000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:16:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,588000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,588000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,588000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1478000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4424000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5902000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5314000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,14000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5300000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5300000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5300000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5300000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51700000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51700000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52183000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,450000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,450000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,450000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1660000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5021000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6681000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6231000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6218000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6218000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6218000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6218000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52903000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,599000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,599000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,599000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1556000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4472000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6028000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5429000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5419000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5419000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5419000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5419000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54200000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54200000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52961000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 16:11:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3478000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3478000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3478000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1485000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4400000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5885000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2407000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2402000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2402000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2402000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2402000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60100000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60100000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53911000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,2012-11-05 16:16:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,380000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,380000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,380000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2298000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4901000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7199000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6819000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6810000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6810000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6810000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6810000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55116000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55116000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54900000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,417000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,417000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,417000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2151000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4430000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6581000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6164000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,41000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,41000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6123000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6123000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6123000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6123000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,76500000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76500000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,78748000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,451000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,451000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,451000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2496000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7112000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9608000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9157000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,76000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,76000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9081000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9081000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9081000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9081000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83410000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 16:11:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,240000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,240000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,240000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3797000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7254000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11051000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10811000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,116000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,116000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10695000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10695000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10695000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10695000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,89100000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,89100000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,89504000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 16:12:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4276000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7926000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12202000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12165000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,116000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,116000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12049000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12049000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12049000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12049000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86200000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86200000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85715000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6320000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11668000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17988000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17958000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,130000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,130000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17828000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17828000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17828000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17828000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,93800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,93800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,92968000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7952000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13799000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21751000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21723000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,228000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,228000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21495000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21495000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21495000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21495000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97700000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97700000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99048000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:11:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8057000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16952000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25009000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24994000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,208000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,208000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24786000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24786000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24786000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24786000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99100000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99100000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99497000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,120000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,167000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,167000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10419000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18183000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28602000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28555000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,189000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,189000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28366000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28366000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28366000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28366000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97300000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97300000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,97248000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24261000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16295000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40556000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-40552000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,177000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,177000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40375000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40375000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40375000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40375000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100900000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100900000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100197000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21119000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18379000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39498000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-39497000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,119000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,119000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39378000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39378000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39378000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39378000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101000000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,101000000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100349000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:38:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,39000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20308000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18729000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39037000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38998000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,92000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,92000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38906000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38906000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38906000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38906000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100756000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:18:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-4000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,21000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2500000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2500000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-2483000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22616000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20466000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43082000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-45565000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,111000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,111000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-45454000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,330000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45784000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45784000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-45784000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100900000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100900000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100630000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27491000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22775000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50266000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-50262000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,500000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,500000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-49762000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49762000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49762000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-49762000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,110600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,110600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,111346000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,97000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,97000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,774000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,774000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-677000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50768000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20478000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71246000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-71923000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,601000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,601000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-71322000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-71322000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-71322000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-71322000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113200000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113200000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113308000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5268000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5268000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1320000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1320000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3948000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50534000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25813000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,76347000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-72399000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,786000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,786000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-71613000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-71613000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-71613000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-71613000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,117400000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117400000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,117497000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:27:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11966000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-4000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11962000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,981000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,981000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10981000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57663000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30218000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1331000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,89212000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-78231000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,876000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,876000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-77355000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1341000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78696000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78696000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-78696000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,116000000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116000000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115858000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15286000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15286000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2938000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2938000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12348000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,65745000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35409000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,101154000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-88806000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,963000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,963000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-87843000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-87843000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-87843000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-87843000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,122000000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.72
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,122000000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.72
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,121651000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.72
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30475000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30475000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2224000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2224000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28251000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,61125000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34180000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,982000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,96287000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-68036000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,993000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,993000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-67043000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,398000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-67441000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-67441000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-67441000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,122600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,122600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,122122000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:32:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35578000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35578000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2135000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2135000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33443000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,61588000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36421000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1078000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,99087000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-65644000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1063000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1063000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-64581000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,667000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65248000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65248000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-65248000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,123100000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.53
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,123100000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.53
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,122484000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.53
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43562000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43562000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1780000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1780000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41782000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66604000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43179000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1923000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,111706000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-69924000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1107000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1107000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-68817000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,54000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-68871000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-68871000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-68871000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,122600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,122600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,122600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48868000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48868000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2153000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2153000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,46715000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60926000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39276000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1332000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,101534000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-54819000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1170000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1170000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-53649000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,647000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54296000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54296000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-54296000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,123400000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,123400000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,124727000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57063000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57063000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3562000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3562000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,53501000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,69472000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46592000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1516000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,117580000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-64079000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1279000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-247000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1032000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-63047000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,219000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-63266000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-63266000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-63266000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,124100000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,124100000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,124910000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 18:06:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,58305000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,58305000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3839000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3839000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,54466000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,61089000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,53112000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1536000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,115737000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-61271000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1229000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1720000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-491000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-61762000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,376000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62138000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62138000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-62138000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,124300000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,124300000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,125009000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 18:04:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59571000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59571000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2823000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2823000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56748000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,74271000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48183000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1569000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,124023000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-67275000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1670000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,127000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1797000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-65478000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65492000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65492000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-65492000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,126400000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,126400000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,126583000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,62959000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,62959000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2950000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2950000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,60009000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,93319000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52923000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1630000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,147872000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-87634000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2934000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2934000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-84929000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,375000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-85304000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-85304000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-85304000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,144600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.59
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,144600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.59
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,143981000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.59
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83205000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83205000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2958000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2958000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,80247000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,67981000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,67320000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2037000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,137338000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-57091000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2527000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2515000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-54576000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,365000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54941000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54941000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-54941000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,144600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,144600000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,144314000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 18:06:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,94586000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,94586000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2416000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2416000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,92170000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,72696000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62622000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2273000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,137591000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-45421000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2432000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,747000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3179000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42242000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-264000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41978000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41978000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41978000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,144800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,144800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,145906000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 18:04:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,98326000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,98326000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3020000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3020000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,95306000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,91642000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57520000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2314000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,151476000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-56399000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3272000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,262000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3534000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-52636000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,400000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53036000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53036000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-53036000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,147000000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,147000000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,147199000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
